Episode 347 - The Case for Index Funds

Episode Summary

Executive Summary: The episode makes a detailed case for low-cost, cap-weighted total market index funds over active management, arguing they win on fees, diversification, taxes, simplicity, and alignment with financial theory. The hosts use academic research and industry data to show most active funds underperform after costs, while also warning that not all “index funds” are truly passive or cheap. The aftershow includes a health update from Ben and a listener story illustrating the real-life impact of sound investing education.

Main Topics: Why index funds are usually the right default (Priority: 5/5): The hosts frame low-cost index funds as the primary investment vehicle most investors should use, emphasizing that objections usually come from misinformation, conflicts of interest, or misunderstanding of evidence. Fees and hidden trading costs (Priority: 5/5): A major argument is that index funds are much cheaper than active funds, and those lower costs meaningfully improve long-term returns. They also distinguish MER from TER and note that trading costs can be substantial in active strategies. Diversification and stock return skewness (Priority: 5/5): The discussion highlights that most individual stocks underperform while a small minority drive market returns, making broad diversification essential and concentrated stock picking statistically disadvantageous. Evidence from fund-performance research (Priority: 5/5): The hosts cite Jensen, Sharpe, Fama-French, Morningstar, SPIVA, and Bessembinder to show that active funds may add little or no value before fees and generally fail to beat index funds after fees. Simplicity, tax efficiency, and investor behavior (Priority: 4/5): Index funds reduce complexity, make it easier to stay disciplined, and often improve after-tax outcomes because they trade less and generate fewer taxable distributions. Misleading forms of 'indexing' (Priority: 4/5): They warn that many sector, thematic, and custom ‘index’ products are effectively active bets with passive wrappers, and should not be confused with true total-market indexing. Listener impact and health update (Priority: 3/5): Ben shares his testicular cancer diagnosis and prognosis, and the aftershow reads a moving listener message about how the podcast helped protect a family from concentrated, risky investing.

Key Arguments: Low-cost index funds minimize fees and trading costs, leaving more of market returns in investors’ pockets. Because market returns are concentrated in a relatively small number of winning stocks, broad ownership is a more reliable way to capture long-term equity growth. Active management is a negative-sum game after costs: even if some managers have skill, fees and trading costs usually consume the advantage. Most active funds underperform over time, and prior outperformance is not a reliable predictor of future success. Index funds are tax-efficient because lower turnover means fewer taxable distributions for taxable investors. Index investing is simpler, easier to maintain, and therefore better aligned with disciplined long-term behavior. Theoretical finance supports cap-weighted indexing through Markowitz diversification theory, CAPM, and market efficiency research. Not all ETFs or indexes are truly passive; thematic and sector products can be active risk bets disguised as indexing.

Data Points: Canadian active-fund asset share: around 80% - Most fund assets in Canada are still in active funds. Weighted average fee for Canadian index funds: 0.19% - Average cost cited for Canadian index funds/ETFs. Average fee for active F-class mutual funds in Canada: 0.85% - Active funds sold in fee-based accounts without advice embedded in the fee. Average commission-based mutual fund fee in Canada: closer to 2% - Includes embedded advisor compensation via trailing commissions. Canadian investor awareness of lower index-fund costs: 31% - OSC 2022 survey found only this share knew index funds have lower fees/expenses than active funds. U.S. stocks with lifetime returns above T-bills (1926-2016): 42.6% - Bessembinder data showing many stocks fail to beat even short-term Treasury bills over a lifetime. U.S. stocks with negative lifetime returns: just over 50% - Bessembinder data illustrating skewness in stock returns. U.S. stocks that lost 100% of value: about 12% - Bessembinder sample from 1926-2016. U.S. stocks beating the market over lifetime buy-and-hold: 30.8% - Bessembinder finding on the share of stocks outperforming the market. U.S. equity mutual funds underperforming SPY before fees: 54.8% - Bessembinder 2023 sample of U.S. equity mutual funds from 1991-2020. U.S. equity mutual funds beating SPY after fees: 30.3% - Same study, full sample after fund fees. SPIVA U.S. equity mutual funds beating S&P Composite 1500 over 20 years: fewer than 6% - SPIVA report for the 20 years ending June 2024. Jensen study sample: 115 mutual fund managers (1945-1964) - Original alpha paper found no average outperformance versus the market. ARKK annualized return over last 3 years ending Feb. 26, 2025: -5.92% - Used as an example of hype-driven thematic performance disappointment. S&P 500 annualized return over last 3 years ending Feb. 26, 2025: 12.37% - Benchmark used for comparison against ARKK. ARKK since inception annualized return: 11.43% - Compared with S&P 500's 13.12% since inception in the discussion. S&P 500 since inception annualized return: 13.12% - Comparison to ARKK since inception. ARKK annualized return from Oct. 2014 to Feb. 12, 2021: 40.3% - Illustrates how exceptional short-run performance can attract assets before reversal. S&P 500 annualized return from Oct. 2014 to Feb. 12, 2021: 13.58% - Benchmark during ARKK's surge period. HMMJ annualized return since 2017: -14.64% - Example of a thematic cannabis ETF with poor long-term performance. HMMJ vs. ARC peak-period comparison: about -22% vs. -24% annualized - Discussed as a rough comparison from the 2021 peak onward.

Pivotal Quotes: "With a few exceptions, most investors should be using low-cost index funds as their primary investment vehicle." — Benjamin Felix: Opening thesis of the episode’s main argument. "In investing, you get what you don't pay for." — John Bogle (quoted by Benjamin Felix): Used to explain why higher fees usually reduce, rather than improve, investor outcomes. "Index funds are consistent with foundational finance theory." — Benjamin Felix: Summarizing the theoretical case linking indexing to Markowitz, Sharpe, and Fama.

Implications: For most investors, the evidence strongly favors broad, low-cost, cap-weighted index funds over active or thematic products. Advisors and savers should focus on costs, diversification, and behavior, not past performance narratives or marketing labels.